Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-26 @ 8:35 AM
Study NCT ID:
NCT01074359
Status:
TERMINATED
Last Update Posted:
2011-04-22
First Post:
2010-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point Mutation
Sponsor:
Penwest Pharmaceuticals Co.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MEL01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Thomas Sciascia, MD/Chief Medical Officer and VP Clinical Operations and Regulatory Affairs
Old Organization:
Penwest Pharmaceuticals Co.